Vertex Pharmaceuticals Inc. (VRTX)

Index:

Nasdaq 100

$ 470.62
   
  • Change Today:
    $0.31
  • 52 Week High: $472.24
  • 52 Week Low: $463.00
  • Currency: US Dollars
  • Shares Issued: 235.99m
  • Volume: 540,848
  • Market Cap: $111,061m
  • RiskGrade: 164
  • Beta: 0.00

VRTX Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Listings

Index: S&P 500, Nasdaq 100, Nasdaq Composite
ISIN: US92532F1003

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

VRTX Market Data

Currency US Dollars
Share Price $ 470.62
Change Today $ 0.31
% Change 0.06 %
52 Week High $472.24
52 Week Low $463.00
Volume 540,848
Shares Issued 235.99m
Market Cap $111,061m
Beta 0.00
RiskGrade 164

What The Brokers Say

Strong Buy 9
Buy 11
Neutral 8
Sell 1
Strong Sell 1
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 19-Feb-2026

Time Volume / Share Price
14:19 45 @ $470.62
14:19 75 @ $470.62
14:19 100 @ $470.62
14:19 80 @ $470.62
14:19 100 @ $470.61

Top of Page